502 related articles for article (PubMed ID: 21199955)
1. Strain-specific activation of the NF-kappaB pathway by GRA15, a novel Toxoplasma gondii dense granule protein.
Rosowski EE; Lu D; Julien L; Rodda L; Gaiser RA; Jensen KD; Saeij JP
J Exp Med; 2011 Jan; 208(1):195-212. PubMed ID: 21199955
[TBL] [Abstract][Full Text] [Related]
2. Toxoplasma gondii rhoptry 16 kinase promotes host resistance to oral infection and intestinal inflammation only in the context of the dense granule protein GRA15.
Jensen KD; Hu K; Whitmarsh RJ; Hassan MA; Julien L; Lu D; Chen L; Hunter CA; Saeij JP
Infect Immun; 2013 Jun; 81(6):2156-67. PubMed ID: 23545295
[TBL] [Abstract][Full Text] [Related]
3. Transcriptomic analysis reveals Toxoplasma gondii strain-specific differences in host cell response to dense granule protein GRA15.
Liu Q; Gao WW; Elsheikha HM; He JJ; Li FC; Yang WB; Zhu XQ
Parasitol Res; 2018 Sep; 117(9):2785-2793. PubMed ID: 29916065
[TBL] [Abstract][Full Text] [Related]
4.
Sangaré LO; Yang N; Konstantinou EK; Lu D; Mukhopadhyay D; Young LH; Saeij JPJ
mBio; 2019 Jul; 10(4):. PubMed ID: 31311877
[TBL] [Abstract][Full Text] [Related]
5. Activation of NF-κB signaling by the dense granule protein GRA15 of a newly isolated type 1 Toxoplasma gondii strain.
Guo G; Cui J; Song L; Tang L; Fan S; Shen B; Fang R; Hu M; Zhao J; Zhou Y
Parasit Vectors; 2022 Sep; 15(1):347. PubMed ID: 36175964
[TBL] [Abstract][Full Text] [Related]
6. The
Thind AC; Mota CM; Gonçalves APN; Sha J; Wohlschlegel JA; Mineo TWP; Bradley PJ
mSphere; 2023 Oct; 8(5):e0026323. PubMed ID: 37768053
[No Abstract] [Full Text] [Related]
7. WITHDRAWN: Toxoplasma gondii virulence factor ROP18 inhibits the host NF-κB pathway by promoting p65 degradation.
Du J; An R; Chen L; Shen Y; Chen Y; Cheng L; Jiang Z; Zhang A; Yu L; Chu D; Shen Y; Luo Q; Chen H; Wan L; Li M; Xu X; Shen J
J Biol Chem; 2014 May; 289(18):12578-92. PubMed ID: 24648522
[TBL] [Abstract][Full Text] [Related]
8. Human innate immunity to Toxoplasma gondii is mediated by host caspase-1 and ASC and parasite GRA15.
Gov L; Karimzadeh A; Ueno N; Lodoen MB
mBio; 2013 Jul; 4(4):. PubMed ID: 23839215
[TBL] [Abstract][Full Text] [Related]
9. The GRA15 protein from
Wang P; Li S; Zhao Y; Zhang B; Li Y; Liu S; Du H; Cao L; Ou M; Ye X; Li P; Gao X; Wang P; Jing C; Shao F; Yang G; You F
J Biol Chem; 2019 Nov; 294(45):16494-16508. PubMed ID: 31416833
[No Abstract] [Full Text] [Related]
10. The
Glausen TG; Carrillo GL; Jin RM; Boyle JP; Saeij JPJ; Wohlfert EA; Fox MA; Blader IJ
mBio; 2021 Jun; 12(3):e0133121. PubMed ID: 34154412
[TBL] [Abstract][Full Text] [Related]
11.
Ihara F; Fereig RM; Himori Y; Kameyama K; Umeda K; Tanaka S; Ikeda R; Yamamoto M; Nishikawa Y
Front Immunol; 2020; 11():1709. PubMed ID: 32849602
[No Abstract] [Full Text] [Related]
12. Hammondia hammondi harbors functional orthologs of the host-modulating effectors GRA15 and ROP16 but is distinguished from Toxoplasma gondii by a unique transcriptional profile.
Walzer KA; Wier GM; Dam RA; Srinivasan AR; Borges AL; English ED; Herrmann DC; Schares G; Dubey JP; Boyle JP
Eukaryot Cell; 2014 Dec; 13(12):1507-18. PubMed ID: 25280815
[TBL] [Abstract][Full Text] [Related]
13. Toxoplasma gondii clonal strains all inhibit STAT1 transcriptional activity but polymorphic effectors differentially modulate IFNγ induced gene expression and STAT1 phosphorylation.
Rosowski EE; Saeij JP
PLoS One; 2012; 7(12):e51448. PubMed ID: 23240025
[TBL] [Abstract][Full Text] [Related]
14. Genetic basis for phenotypic differences between different Toxoplasma gondii type I strains.
Yang N; Farrell A; Niedelman W; Melo M; Lu D; Julien L; Marth GT; Gubbels MJ; Saeij JP
BMC Genomics; 2013 Jul; 14():467. PubMed ID: 23837824
[TBL] [Abstract][Full Text] [Related]
15. Identification of host proteins interacting with Toxoplasma gondii GRA15 (TgGRA15) by yeast two-hybrid system.
Liu Q; Li FC; Elsheikha HM; Sun MM; Zhu XQ
Parasit Vectors; 2017 Jan; 10(1):1. PubMed ID: 28049510
[TBL] [Abstract][Full Text] [Related]
16. Type II Toxoplasma gondii induction of CD40 on infected macrophages enhances interleukin-12 responses.
Morgado P; Sudarshana DM; Gov L; Harker KS; Lam T; Casali P; Boyle JP; Lodoen MB
Infect Immun; 2014 Oct; 82(10):4047-55. PubMed ID: 25024369
[TBL] [Abstract][Full Text] [Related]
17. Toxoplasma type II effector GRA15 has limited influence in vivo.
Merritt EF; Kochanowsky JA; Hervé P; Watson AA; Koshy AA
PLoS One; 2024; 19(3):e0300764. PubMed ID: 38551902
[TBL] [Abstract][Full Text] [Related]
18. Toxoplasma polymorphic effectors determine macrophage polarization and intestinal inflammation.
Jensen KD; Wang Y; Wojno ED; Shastri AJ; Hu K; Cornel L; Boedec E; Ong YC; Chien YH; Hunter CA; Boothroyd JC; Saeij JP
Cell Host Microbe; 2011 Jun; 9(6):472-83. PubMed ID: 21669396
[TBL] [Abstract][Full Text] [Related]
19.
Bando H; Lee Y; Sakaguchi N; Pradipta A; Sakamoto R; Tanaka S; Ma JS; Sasai M; Yamamoto M
Front Cell Infect Microbiol; 2019; 9():140. PubMed ID: 31119110
[No Abstract] [Full Text] [Related]
20. ROP16-Mediated Activation of STAT6 Suppresses Host Cell Reactive Oxygen Species Production, Facilitating Type III Toxoplasma gondii Growth and Survival.
Kochanowsky JA; Thomas KK; Koshy AA
mBio; 2021 Mar; 12(2):. PubMed ID: 33653884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
